Search Videos and More

Showing 1 - 12 of 184 results

Previous| 1 | 2 | 3 ...16 |Next


New Drug Extends Survival for Late-Stage Prostate Cancer Patients News

New Drug Extends Survival for Late-Stage Prostate Cancer Patients

Baptist Health Miami Cancer Institute is among the first cancer centers in the region to offer an innovative radiopharmaceutical therapy that can extend survival and increase quality of life for patients with stage 4 metastatic prostate cancer, according to radiation oncologist Adeel Kaiser, M.D. 
Patient Undergoes Milestone 2nd High-Intensity Focused Ultrasound (HiFU) for Essential Tremor News

Patient Undergoes Milestone 2nd High-Intensity Focused Ultrasound (HiFU) for Essential Tremor

HiFU offers an incisionless outpatient procedure for patients with essential tremor or Parkinson’s disease who don’t get acceptable tremor relief from medications.
Gallbladder Cancer: Progress and Hope for Future Breakthroughs News

Gallbladder Cancer: Progress and Hope for Future Breakthroughs

For Gallbladder Cancer Awareness Month, Horacio J. Asbun, MD, and Domenech Asbun, MD, shared their thoughts and strategies for treating patients with this disease from the surgical and clinical sides.
McGinn Family Tradition: Inspiring the Next Generation of Coronary Bypass Surgeons News

McGinn Family Tradition: Inspiring the Next Generation of Coronary Bypass Surgeons

The old adage that the apple doesn’t fall far from the tree is certainly true in the McGinn family.
Study: Ablative Stereotactic Magnetic Resonance-Guided Adaptive Radiation Therapy May Improve Overall Survival in Patients with Pancreatic Cancer News

Study: Ablative Stereotactic Magnetic Resonance-Guided Adaptive Radiation Therapy May Improve Overall Survival in Patients with Pancreatic Cancer

A study co-led by researchers at Miami Cancer Institute, part of Baptist Health South Florida, found that ablative stereotactic magnetic resonance (MR)-guided adaptive radiation therapy may improve local control (LC) and overall survival (OS) in patients with borderline resectable (BRPC) and locally advanced pancreas cancer (LAPC).
Inaugural Marcus Neuroscience Institute Spine Symposium News

Inaugural Marcus Neuroscience Institute Spine Symposium

The Inaugural Marcus Neuroscience Institute Spine Symposium is a one-day academic event designed to help attendees expand their knowledge of the latest advances in the field of spine surgery through didactic lectures, interactive panel discussions and case-based presentations.
Marc Gibber, M.D, is New Medical Director at Baptist Health Bethesda Hospital East News

Marc Gibber, M.D, is New Medical Director at Baptist Health Bethesda Hospital East

Board-certified cardiothoracic surgeon Marc Gibber, M.D., joins Baptist Health as the new medical director and chief of cardiothoracic surgery at Baptist Health Bethesda Hospital East.
When Your Patient Needs an Oral Medicine Evaluation News

When Your Patient Needs an Oral Medicine Evaluation

Whether your patient is being treated for cancer, has an autoimmune disease or an inflammatory condition that is causing an oral problem apart from the teeth and gums, they may benefit from an evaluation and treatment by an oral medicine specialist.
Neurologist G. Peter Gliebus, M.D., Joins Baptist Health News

Neurologist G. Peter Gliebus, M.D., Joins Baptist Health

G. Peter Gliebus, M.D., a board-certified neurologist with subspecialty certification in behavioral neurology and neuropsychiatry, has joined Marcus Neuroscience Institute, part of Baptist Health, at Boca Raton Regional Hospital.
Miami Cancer Institute Leads First-in-World Brain Metastasis Trial News

Miami Cancer Institute Leads First-in-World Brain Metastasis Trial

Baptist Health Miami Cancer Institute is leading a groundbreaking clinical trial that is studying the use of a new medication combined with stereotactic radiosurgery to combat metastatic brain cancer.
Miami Cancer Institute Publication Analyzes Role of Tissue-Agnostic Therapies for the Treatment of Primary Brain Tumors News

Miami Cancer Institute Publication Analyzes Role of Tissue-Agnostic Therapies for the Treatment of Primary Brain Tumors

Researchers from Miami Cancer Institute, part of Baptist Health South Florida, recently published a study in Trends in Cancer that analyzes the use of tissue-agnostic therapeutics in patients with primary brain tumors (PBTs). The publication describes the current and potential impact of tissue-agnostic therapies on the management of PBTs. As part of the publication, the researchers discuss data from clinical trials of tissue-agnostic targets for PBTs in the context of challenges in managing these tumors. They also describe additional tissue-agnostic targets that hold promise for benefiting patients with PBTs.
Miami Cancer Institute Precision Oncology Symposium, Second Annual News

Miami Cancer Institute Precision Oncology Symposium, Second Annual

Live Symposium Friday-Saturday, April 19-20, 2024 The Ritz-Carlton, Coconut Grove, Miami, Florida

Showing 1 - 12 of 184 results

Previous| 1 | 2 | 3 ...16 |Next